Alfred Chung



Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system.

Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma.

After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology.

Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists.

  • Education

    Feinberg School of Medicine, MD, 2014

  • Residencies

    Stanford Medicine, Internal Medicine, 2017

  • Fellowships

    Stanford Medicine, Hematology and Oncology, 2020

  • Academic Title

    Assistant Professor

Each patient has a unique story and perspective. I am committed to providing compassionate medical care to people of all backgrounds.

Clinics I work with

Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program

400 Parnassus Ave., Fourth Floor
San Francisco, CA 94143